Vivo Bio Tech enterprise value

·Pharma & HealthChart ›
MultiplesEnterprise valuePer share
Share price at each year-end
Tap a line for its trendCurrentlast closeFY25Mar 2025FY24Mar 2024
21.4——
1.21.21.3
51.851.870.8
72.0——
50.650.669.5
₹47.06——
130130125
39.8%39.8%56.6%
0.72×——
1.54×——
3.46×——
6.11×——
6.08×——
Reference items — trailing FY values
46.746.744.9
20.820.821.1
11.811.811.8
11.811.815.8
−10.4−10.47.9
−11.7−11.74.9
22.322.38.0
Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

VIVOBIOT₹13.98

Vivo Bio Tech Limited

· Pharma & Health
₹ CroreMcap ₹21.4 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
Current
last close
Market Capitalization——21.4
- Cash, Equiv & ST Investments1.31.21.2
+ Total Debt70.851.851.8
Enterprise Value——72.0
Net Debt (memo)69.550.650.6
EV per Share——47.06
Total Capital125.2130.0130.0
Total Debt/Total Capital56.5639.8539.85
Total Debt/EV——0.72
EV/Sales——1.54
EV/EBITDA——3.46
EV/EBIT——6.11
EV/Operating Cash Flow——6.08
Reference Items — Trailing FY Values
Sales44.946.746.7
EBITDA21.120.820.8
EBIT11.811.811.8
Operating Cash Flow15.811.811.8
Free Cash Flow7.9-10.4-10.4
FCFF (free cash flow to the firm)4.9-11.7-11.7
Capital Expenditure8.022.322.3
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY25 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 85%.